Explore Myriapod NGS
Accelerating Precision Medicine for Everyone
With simplicity, speed, and adaptability, Myriapod NGS enhances laboratory efficiency and ensures reliable, fast and clinically relevant results — driving precision medicine forward.
Myriapod NGS Solid tumor
Adapting to your lab advancing care for your patients
Clinically
approved
biomarkers
targeted testing
- Focus on clinically approved biomarkers
- Low multigene testing diseases
- Fast and simple workflow
High-plex multigene
cancer testing
- Medium to high multigene testing diseases
- Actionable and fast results
- Including clinical and preclinical targets
Genomic Comprehensive
Profile
- Second level advanced testing
- Rare tumors
- Clinical trail and transliational research
Clinically approved biomarkers targeted testing
- Focus on clinically approved diagnostic biomarkers
- Low multigene testing disease
- Fast results
High-plex multigene cancer testing
- High-plex genes testing
- Comprehensive biomarkers content
- Including clinical and pre clinical targets
Genomic Comprehensive Profile
- Second level advanced testing
- Rare tumors
- Clinical trail and transliational research
Ready to use reagents
TAT <4 days
Sample flexibility
On-premise
data analysis
Flexible throughput
Low imput
Myriapod® NGS PGX Sign Panel
Advanced Pharmacogenetics Signature for Personalized Therapy
20 genes- extensive gene coverage
> 1000 SNV analysed
>95 associated drugs
Based on CPIC & DPWG guidelines
Ready to use format
Integrated data management system